Healthcare Equipment and Supplies
Company Overview of Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. designs, develops, and sells wearable robots or exoskeletons for use in the medical, military, industrial, and consumer markets in North America, Western Europe, the Middle East, and South Africa. The company operates through Engineering Services and Medical segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, stroke, and other lower-extremity paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskel...
1414 Harbour Way South
Richmond, CA 94804
Founded in 2005
Key Executives for Ekso Bionics Holdings, Inc.
Co-Founder, Chief Executive Officer and Director
Total Annual Compensation: $401.1K
President and Chief Commercial Officer
Total Annual Compensation: $201.7K
Co-Founder and President of Ekso Labs Division
Total Annual Compensation: $323.0K
Chief Financial Officer
Total Annual Compensation: $323.0K
Compensation as of Fiscal Year 2014.
Ekso Bionics Holdings, Inc. Key Developments
Ekso Bionics Holdings, Inc. Establishes New Headquarters in Freiburg, Germany
Nov 12 15
Ekso Bionics Holdings, Inc. announced that it has established a new regional headquarters, based in Freiburg, Germany, to further strengthen its European presence and better serve German-speaking markets. The expansion is being led by Ruediger Hausherr, President, EMEA, Ekso Bionics, and marks an integral step in the company's development of its Europe, Middle East, and Africa (EMEA) business.
Ekso Bionics Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and First Nine Months Ended September 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016
Nov 5 15
Ekso Bionics Holdings, Inc. announced unaudited consolidated earnings results for the third quarter and first nine months ended September 30, 2015. For the quarter, the company announced total revenue of $2,915,000 compared to $1,588,000 for the same period a year ago. Loss from operations was $5,181,000 compared to $3,732,000 for the same period a year ago. Net loss was $5,185,000 compared to net income of $12,024,000 for the same period a year ago. Basic and diluted net loss per share was $0.05 compared to basic earnings per share of $0.15 and diluted loss per share of $0.04 for the same period a year ago. The net income in the 2014 period was primarily due to a non-cash gain of $15.8 million related to warrant liabilities.
For the first nine months, the company announced total revenue of $6,718,000 compared to $3,847,000 for the same period a year ago. Loss from operations was $14,909,000 compared to $11,935,000 for the same period a year ago. Net loss was $14,945,000 compared to $13,614,000 for the same period a year ago. Basic and diluted net loss per share was $0.15 compared to $0.18 for the same period a year ago. Net cash used in operating activities was $13,082,000 compared to $12,296,000 for the same period a year ago.
The company is expecting to see gross margins improving in 2016.
Ekso Bionics Holdings, Inc. to Report Q3, 2015 Results on Nov 05, 2015
Oct 30 15
Ekso Bionics Holdings, Inc. announced that they will report Q3, 2015 results at 10:18 PM, GMT Standard Time on Nov 05, 2015
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|